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FÖRSTER RESONANCE ENERGY TRANSFER (FRET) 
AS AN OPTICAL READOUT FOR TRANSCRIPTION FACTOR-DNA 
BINDING IN BIOSENSING APPLICATIONS 
THUY THI HA NGUYEN 
ABSTRACT 
 An alternative molecular recognition approach was developed for sensing small 
molecule analytes using the differential binding of an allosteric transcription factor (TF, 
specifically TetR) to its cognate DNA as the molecular recognition element coupled with 
Förster resonance energy transfer (FRET) to yield an internally calibrated optical signal 
transduction mechanism. Sensors were evaluated comprising Cy5-modified DNA (FRET 
acceptor) with either a tdTomato-TetR fusion protein (FP-TF) or quantum dot-TetR 
conjugate (QD-TF) as the FRET donor by measuring the ratio of acceptor and donor 
fluorescence intensities (FA/FD) with titrations of a derivative of the antibiotic tetracycline, 
anhydrous tetracycline (aTc). A proof-of-concept FRET-based biosensor was successfully 
demonstrated through the modulation of FA/FD signal intensities based on varying analyte 
concentrations. Sensor design parameters affecting overall signal-to-noise ratio and 
sensitivity of the sensors are also identified. 
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1.1 Small Molecule Detection 
Small molecules can be defined as low molecular weight organic molecules which 
are typically less than 1000 Da in size. This category includes a wide variety of compounds 
that are biologically, pharmacologically, or environmentally relevant, making the detection 
and quantification of these small molecules of great importance in many fields [6, 40]. For 
example, many small molecules are well-known contaminants in food and other 
agricultural products such as mycotoxins [7]. Mycotoxins are a diverse group of organic 
compounds produced by fungal species commonly found in cereals and nuts [47]. The 
negative health effects associated with mycotoxins are numerous, including their 
immunotoxicity, carcinogenicity, and nephrotoxicity [1, 13, 30].  
On the other side of the spectrum, small molecules are of great interest in the 
pharmaceutical field for its potential in clinical medicine as well as in drug screening. 
In clinical medicine, small molecules can be advantageous with its intrinsic ability to 
cross the blood-brain barrier. Furthermore, the detection of many drugs is not only 
diagnostically and clinically relevant but also important for the development of new 
biotherapeutics and for studying the activity, kinetics, and stability of pharmaceuticals 
[18, 40]. 
Conventionally, many small molecules are detected by chromatographic methods 
such as high-performance liquid chromatography (HPLC) with UV and/or fluorescence 
detection (FLD) [22, 31, 46, 47]. These methods provide high sensitivity and specificity 
[44], but comes with major setbacks such as high cost, bulky instrumentation, and laborious 
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and time-consuming steps, making them not suitable for all applications. Biosensors can 
offer a cheaper and faster alternative [40]. 
Biosensors offer many advantages for the detection of small molecules including 
real-time monitoring, high specificity, rapid response, practicality, and convenience [34, 
40]. Many biosensors and bioanalytical assays have been reported utilizing traditional 
enzyme-linked immunosorbent assays (ELISAs) [48, 49] and lateral flow strips [26] to 
fluorescent and electrochemical sensors [39].  
1.2 FRET-based Small Molecule Biosensors 
Generally, biosensors consist of a biorecognition element responsible for capturing 
the target analyte and a transducer, whose properties are altered upon analyte binding [43]. 
Optical transducers are based on measuring a change in optical properties in the presence 
of the analyte, such as absorption, reflectance, or emission, which can be recorded by a 
photodetector [17, 19, 29]. 
Optical biosensors offer many advantages such as high sensitivity, specificity, and 
the opportunity for real-time analysis [14]. Specifically, Förster resonance energy transfer 
(FRET) based biosensors have the advantages of high orthogonality, temporal resolution 
and ease of construction. FRET is a non-radiative dipole-dipole interaction that results in 
energy transfer from a donor molecule to an acceptor molecule. FRET efficiency is 
inversely proportional to the donor-acceptor distance to the sixth power [32]. This makes 
FRET a valuable tool for sensing nanometer scale changes in distance due to 
conformational changes and biomolecular binding.  
FRET-based biosensors typically have a pair of donor and acceptor fluorophores 
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[50] with the ligand binding domain inserted in between. When the target molecule is 
bound, the ligand binding domain induces a conformational change, altering the distance 
of the donor and acceptor fluorophores and leading to a FRET signal change [3]. A wide 
variety of small molecules such as sugar phosphates [41], pyruvate [36], amino acids [28, 
38]; and ions [25, 45] have been detected using FRET-based biosensors. In addition, FRET 
modulation of analyte binding offers the ability for ratiometric measurements, enhancing 
sensitivity. Both the emission intensities of the donor and acceptor can be monitored as 
well as the resulting changes in acceptor-donor emission ratios [8, 9]. 
1.3 Allosteric Transcription Factors as Biorecognition Elements  
In addition to the choice of a transducer, the biorecognition element of a biosensor 
is highly critical. Antibodies continue to be one of the most used biorecognition elements 
due to their exceptional specificity and sensitivity. In addition, nucleic acids, aptamers, 
peptides, and molecularly imprinted polymers (MIPs) are also widely used [ ]. 
However, these recognition elements require synthesis and optimization on a case-by-case 
basis for each small molecule of interest. This can become extremely labor-intensive, 
complex and expensive [2].  
Bacteria have evolved over 3 billion years to respond to a wide range of stimuli. 
One mechanism of sensing is through an allosteric transcription factor. Transcription 
factors (TFs) are regulatory proteins that contain a DNA-binding domain and a ligand-
binding domain. Transcription factors are able to recognize a wide variety of small 
molecules with high specificity and selectivity. In the presence of the target analyte, TF-
DNA binding can be regulated, and therefore, possess an inherent transduction system. 
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This inherent transduction system has been exploited by many research groups for the 
development of whole cell biosensors [35], and molecular beacons for detecting DNA-
binding proteins [23, 24]; yet, it has not been deeply explored for use in in vitro biosensors 
[33]. Recently, Yang et al. demonstrated the ability of utilizing isolated TFs as the 
molecular recognition element for sensing uric acid and oxytetracycline in vitro. They 
showed successful sensing by employing the amplified luminescent proximity 
homogeneous assay technology as the transducing element [33]. 
1.4 Rationale and Specific Aims 
In this proposal, we explore the possibility of using FRET as the optical readout for 
TF-DNA binding by labelling the TF and DNA with fluorescent donor and acceptor 
molecules, respectively. When the TF and DNA are bound, the donor and acceptor 
molecules are in close enough proximity to enable FRET. This causes a decrease in donor 
emission, and an increase in acceptor emission. In the presence of the target analyte, the 
affinity of the TF for the DNA is greatly reduced, resulting in the unbinding of the TF-
DNA complex. This results in the recovery of donor emission, and reduction in acceptor 
emission. By observing the analyte-induced changes in fluorescence of both the donor and 
acceptor molecules, we can obtain a ratiometric signal output to facilitate the quantification 
of the target analyte. The strong dependence of FRET on distance, however, can become 
the limiting factor on sensor sensitivity if the geometry and optical properties of the sensor 
components are not considered. Therefore, we also explore the differences in sensor 
performance with different donor molecules and configurations. 
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Specific Aim 1: Demonstrate feasibility of FRET as an optical readout of TF-DNA binding. 
We will attempt to demonstrate the feasibility of utilizing FRET as the optical 
readout of TF-DNA binding by developing a model system utilizing a well-known and 
well-studied TF, TetR. It has been shown in literature that TetR specifically binds to a 
palindrome DNA sequence and unbinds the DNA in the presence of anhydrous tetracycline 
(aTc). The degree of unbinding of TetR is dependent on the concentration of aTc, which 
can be observed by the intensity of the observed FRET signal in the proposed biosensor.  
We propose to use a recombinant fusion protein, TetR-tdTomato to serve as the 
FRET donor and Cy5-labelled DNA as the FRET acceptor. tdTomato and Cy5 were 
specifically chosen as a FRET pair due to their high spectral overlap and potential for high 
FRET efficiency. Furthermore, recombinant proteins can be easily expressed in E. coli at 
high yields and dye-labelled DNA are readily available commercially, making the 
production and assembly of the biosensor approachable. We expect to provide proof-of-
concept data demonstrating the ability to detect and measure the modulation of TF-DNA 
binding in the presence of the analyte (aTc) via FRET.  
 
Specific Aim 2: Characterize and optimize FRET system for improved sensitivity and signal 
output.  
Upon demonstrating FRET as a viable sensor output, we will probe the effects of 
different FRET pairs on the biosensor’s sensitivity and signal-to-noise ratio. We propose 
to introduce quantum dots (QDs) as one or both of the FRET molecules in the biosensor in 
an attempt to improve photostability, sensitivity, and signal intensity.  
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QDs have broadband absorption profiles and high molar extinction coefficients, 
making them efficient FRET donors and acceptors. Their broadband absorption allows for 
selective excitation of the donor molecule only (i.e. no direct acceptor excitation), reducing 
background noise. Increased brightness and photostability gained from QDs as compared 
to fluorescent proteins and dyes allows for the biosensor to be applied to a broader range 
of applications such as point-of-care diagnostics and continuous real-time sensing. We 
expect to pinpoint the critical parameters in our sensor design that can be tuned for the 
desired sensor sensitivity and dynamic range by comparing the effects of utilizing different 
sensor components.
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2. MATERIALS AND METHODS 
2.1 Quantum Dot Synthesis. 
Cadmium oxide (CdO; 99.95%, Alfa Aesar), sulfur (99.95%, ACROS Organics), 
and 1-octadecene (ODE; 90%, ACROS Organics) were used as purchased from Fisher 
Scientific. Zinc acetate (99.99%), selenium (99.99%; pellets), oleic acid (OA; 90%), 
oleylamine (80%–90%), trioctylphosphine (TOP; 97%), and trioctylphosphine oxide 
(TOPO; ReagentPlus®, 99%) were used as purchased from Sigma-Aldrich. HPLC- grade 
solvents including hexanes (Fisher Scientific), methanol (Honeywell), chloroform (J.T. 
Baker), and ethanol (Sigma- Aldrich) were bought and used without further purification. 
CdSe cores were nucleated using a modification of a previously described protocol 
[21]. Briefly, 1 g TOPO, 8 ml ODE, and 1.9 ml 0.2 M Cd(OA)2 (1:4) were added to a 100 
ml round bottom flask and degassed at room temperature for 30 mins. The flask was then 
heated to 80°C and degassed for another 30 mins. The temperature was raised to 300°C 
under argon atmosphere and a pre-mixed solution of 0.4 ml 1 M TOP:Se, 3 ml oleylamine, 
and 1 ml ODE was immediately injected into the flask. After 3 mins, the flask was removed 
from the heating mantle and cooled to room temperature on a cork ring. Once cooled, the 
raw QD core solution was transferred into an argon atmosphere glovebox and precipitated 
using a mixture of methanol and ethanol. After centrifugation, CdSe cores were re-
suspended in hexanes and stored at 4ºC under air-free conditions for future use. 
A CdS shell was deposited on top of the CdSe cores using a modified successive 
ion layer adsorption and reaction (SILAR) method previously discussed [21]. For this, 5 
ml ODE and 5 ml oleylamine were added to a 100 ml round bottom flask and degassed for 
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30 mins at room temperature and for an additional 30 mins at 80°C. Two hundred nmols 
of CdSe cores in hexanes were injected into the reaction flask and degassed for another 30 
mins at 80°C.  The core solution was heated to 160°C and enough cadmium oleate to coat 
the CdSe cores with a single atomic monolayer of material was added in the form of 0.2 M 
Cd(OA)2 (1:4) in ODE. The reaction was maintained at 160°C for 1 hour before the 
temperature was raised to 240°C, where it was held for 1.5 hr. The same amount of sulfur 
was added in the form of 0.2 M sulfur dissolved in ODE and the reaction annealed for 1 
hour. All subsequent injections and anneals were performed at 240°C with Cd and S 
anneals of 2.5 and 1 hours, respectively until the desired monolayers of CdS was reached. 
An additional 2 layers of ZnS was added on top of the QDs to passivate the surface in 
preparation of water solubilization. The same SILAR method was used as above, but with 
0.2 M Zn(OA)2 (1:4) as the cation precursor and 1 hour anneal times for both Zn and S 
additions. 
The core/shell/shell QDs were then precipitated out of solution to remove any 
excess reagents using a mixture of methanol and ethanol. TEM images were taken to 
determine size distribution. QDs were transferred to water using a zwitterionic ligand CL4 
previously described [42]. Quantum yield measurements were taken using an integrating 
sphere attachment on the Horiba Nanolog. 
2.2 CL4 Ligand Synthesis. 
DL-Thioctic acid (≥98%; ACROS Organics), 1,1′-carbonyldiimidazole (CDI; 97%, 
ACROS Organics), methyl acrylate (≥99%, ACROS Organics), sodium borohydride 
(NaBr4), and silica gel sorbent (230-400 mesh, grade 60) were purchased from Fisher 
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Scientific. Ethylenediamine (≥99%), lithium hydroxide (LiOH; ≥98%), hydrochloric acid 
(HCl; 37%), and sodium hydroxide (NaOH; 50% in H2O) were purchased from Sigma-
Aldrich. 
A short zwitterionic ligand, compact ligand four (CL4) developed by Susumu et al. 
was used to water solubilize the QDs [42]. The ligand was synthesized with modifications 
as previously described [9]. Briefly, 12 g (0.0145 mol) of thioctic acid and 10.36 g (0.064 
mol) of CDI were added to a 250 mL round bottom flask and purged with argon. 120 mL 
of chloroform was added by syringe and the mixture was stirred for 1 hr at room 
temperature under argon. The solution was then added dropwise into a pre-mixed solution 
of 32 mL of ethylene diamine and 120 mL of chloroform via an additional funnel under 
argon atmosphere over the course of 4 hrs with stirring. The mixture was left to stir at room 
temperature overnight. The organic phase was collected using a separatory funnel and the 
aqueous phases was washed an additional three times with chloroform.  
The organic layers were pooled and concentrated to ~80 ml on a rotary evaporator 
to be purified on a silica gel column (CHCl3/MeOH (5:1) eluent). The purified crude 
product was concentrated under vacuum to 60 mL and diluted with 280 mL MeOH. 40 
mL of methyl acrylate was added dropwise and the resulting solution was left to stir for 2 
days under active argon flow at room temperature. The excess methyl acrylate and solvent 
was evaporated off and the product was again purified on a silica column with 
CHCl3/MeOH (20:1) as the eluent instead. The purified product was concentrated to a 
yellow oil. The product was weighed and stored at 4°C for subsequent ring-opening 
immediately prior to QD ligand exchange.  
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To ring open the stored product, 20.9 mg LiOH, 2 mL EtOH and 1 mL DI H2O was 
added for every 0.321 g of product. The mixture was allowed to react for 2 hours at room 
temperature before 4 M HCl was used to adjust the pH of the solution to 8. For every 
0.321 g of product, 60.6 mg of NaBH4 was added and the solution was allowed to stir at 
room temperature for an additional 1.5 hrs. The pH of the solution was adjusted to ~7-8 
and filtered through a cotton plug to remove excess salts and unreacted materials. Excess 
EtOH was evaporated off and the clear liquid was stored at 4°C for ligand exchange. A 
biphasic mixture of QDs in chloroform and CL4 in water was left to stir overnight under 
argon filled glass vials. The ratio of CL4 to QD was adjusted based on QD surface such 
that 2000 molecules of CL4 per unit surface area (nm2) of QD was used in each transfer.   
2.3 Protein Expression and Purification. 
NEB® 5-alpha (Cat# C2987I) and BL21(DE3) (Cat# C2527I) competent 
Escherichia coli cells were purchased from New England Biolabs and used to replicate and 
express plasmids, respectively. LB broth (Lennox; powder), kanamycin sulfate (mixture of 
Kanamycin A (main component) and Kanamycin B and C; powder), isopropyl b-D-
thiogalactopyranoside (IPTG; ≥99%), phosphate buffered saline, pH 7.4 (PBS; packets), 
and lysozyme from chicken egg white (~7000 U/mg; powder(crystalline)) were purchased 
from Sigma-Aldrich. Dextrose (granules (crystalline)), Halt™ protease inhibitor cocktails 
(100X) were purchased from Fisher Scientific. 1,4-Dithiothreitol (DTT; >99% (protease-
free)) was bought and used as is from Gold Biotechnology (St. Louis, MO). Nickel-
nitrilotriacetic acid (Ni-NTA) agarose resin and Strep-tactin® Superflow Plus resin were 
purchased from Qiagen (Germantown, MD) for affinity-tag chromatography purification 
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of proteins. Strep-tactin® Purification Buffer Set was purchased from IBA (Gottingen, 
Germany). Sodium phosphate (NaH2PO4; ≥98%, monobasic monohydrate), sodium 
chloride (NaCl; BioXtra, ≥99.5%), and imidazole (≥99%) were purchased from Sigma for 
buffer preparation used with Ni-NTA agarose resin.  
Acrylamide/Bis-Acrylamide (37.5:1) 40% (w/v) solution (BioBasic, ON, Canada), 
glycine (≥99%, Sigma-Aldrich), N,N,N’,N’-tetramethylethylenediamine (TEMED; ~99%, 
Sigma-Aldrich), ammonium persulfate (APS; ≥98%, Sigma-Aldrich), SDS-PAGE protein 
standards, broad range (unstained, Bio-Rad), tris(hydroxymethyl) aminomethane (ultra 
pure, Research Products International (RPI)), sodium dodecylsulfate (SDS; powder, RPI), 
bromophenol blue (Sigma-Aldrich), 2-mercaptoethanol (BME; ≥99%, Sigma-Aldrich), 
glycerol (≥99.5%, Fisher Scientific), Coomassie Brillant Blue G (250, Sigma-Aldrich), and 
acetic acid (glacial, J.T.Baker) were purchased for SDS-PAGE protein molecular weight 
verification. Protein assay kit II (Bradford reagent) was purchased from Bio-Rad for 
protein quantification. 
Plasmids encoding the gene for His-tagged tetR(C) and tetR(D) (tetR(C),tetR(D)) 
and Strep-tagged fusion protein tetR-tdTomato were generously provided to us by the 
Galagan Lab. Escherichia coli BL21(DE3) were transformed with plasmids following 
standard molecular biology techniques. Cells were grown at 37ºC in LB broth 
supplemented with a final concentration of 0.4% glucose and 33ug/ml kanamycin. Protein 
expression was induced at an OD600 between 0.5 – 1 by adding IPTG to a final 
concentration of 1 mM. The temperature was lowered to 30ºC and cultures were incubated 
for 4 hours. Cells were harvested by centrifugation, re-dispersed in 10 mM PBS, 1 mM 
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DTT, 1X Halt protease inhibitor cocktail, and stored at -80ºC until purification. The fusion 
protein TetR-tdTomato was also expressed following the above methods with the exception 
of an overnight induction with IPTG. 
For purification, a final concentration of 1 mg/ml lysozyme was added to the 
thawed whole cell lysate and allowed to incubate for 1 hour at 4°C. Soluble proteins were 
obtained by centrifugation at 4ºC for 30 mins at 18,000 rpm. Cleared cell lysates were 
purified using a Strep-tactin column for the TetR-tdTomato fusion protein and a Ni-NTA 
column for the TetR-6His proteins. Fractions were collected from the affinity columns and 
analyzed using a 10% and 15% SDS-PAGE gel for TetR-6His proteins and TetR-tdTomato, 
respectively. Fractions containing the protein of interest were pooled, concentrated and 
buffer exchanged into TBS via 10 kDa and 50kDa centrifugal filters for TetR-6His proteins 
and TetR-tdTomato, respectively (Amicon). Concentrations were determined using a 
Bradford assay as well as UV spectroscopy using the molar extinction coefficient of 
tdTomato (138,000 M-1 cm-1). Protein stocks were aliquoted and stored at -80C in 25% 
glycerol and 1 mM DTT until further use.  
2.4 DNA Hybridization. 
The synthetic 28bp tetO-containing oligonucleotide with modified 5’- and 3’-Cy5 
and its complement were purchased from IDT and hybridized to generate double-stranded 
fluorescent probes. Equal molar amounts of each oligonucleotide were mixed with 1X 
nuclease-free duplex buffer (30 mM Hepes pH 7.5, 100 mM KAc, IDT), heated to 95ºC 
for 2 mins and allowed to cool down to room temperature wrapped in aluminum foil to 
prevent photo-oxidation of the Cy5 dye. A scrambled non-binding oligonucleotide 
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sequence was also purchased and hybridized as above for a negative control. 
2.5 FRET Assays. 
Bovine serum albumin (BSA; DNase- and protease-free, Fisher Scientific), tris-
hydrochloride (Tris-HCl; ≥99%, Promega), magnesium chloride hexahydrate (MgCl2; 
≥99%, Sigma-Aldrich), salmon sperm DNA solution (UtraPureTM, Invitrogen), and 
anhydrotetracycline hydrochloride (aTc; Alfa Aesar) were used as purchased. 
Sensors were prepared in a solution of TBS + 0.2% (w/v) BSA and 1X binding 
buffer (20 mM Tris-HCl, 5 mM MgCl2, 5% glycerol, 50 ng/µl salmon sperm DNA). To 
prepare the tdTomato sensor, tetR-tdTomato and Cy5-modified DNA were allowed to 
incubate at a 1:3 ratio. The sensor solution was pipetted into wells of a black, non-binding 
384-well plate. aTc was added into each well such that the final concentrations of the 
components were 200 nM tetR-tdTomato, 600 nM Cy5-modified DNA, and 0-675 nM aTc 
with a final volume of 60ul. For triplicate measurements, each of the above solutions were 
prepared with a final volume of 180 µl in microcentrifuge tubes and pipetted into 3 separate 
wells of 60 µl each. 
To prepare the QD sensor, QDs and TetR-6His were allowed to incubate at a 1:4 
ratio to allow for the tetR-6His to self-assemble on the surface of the QDs [11]. The QD-
tetR conjugates were then incubated with the Cy5-modified DNA at a 1:4.5 ratio. The final 
ratios between the QD, tetR-6His, and Cy5-modified DNA were 1:4:18, respectively. aTc 
was added to the wells above with final concentrations of 50 nM QDs, 200 nM tetR-6His, 
900 nM Cy5-modified DNA, and 0-2700 nM aTc. 
Emission spectra were taken with the MicroMax plate reader attachment on the 
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Horiba Nanolog fluorimeter with tetR-tdTomato excitation set at 500nm and QD excitation 
set at 400nm with a slit width of 2nm and 3s integration time per well. Negative controls 
were prepared exactly the same way using a Cy5-modified scrambled DNA sequence as 
the acceptor to account for collisional quenching of the donor. 
2.6 FRET Analysis. 
The overlap integral J, describes the spectral overlap of the donor emission and 
acceptor absorbance according to the following equation: 
 
where  is the normalized donor emission spectrum and  is the molar extinction 
coefficient of the acceptor as a function of wavelength . The Förster distance R0 is defined 
as the donor-acceptor distance at which 50% FRET efficiency is observed as described by: 
 
where  is 2/3 under the assumption of random dipole orientation,  is the donor 
quantum yield, and  is the solvent refractive index [10]. 
2.7 Sensor Analysis. 
Raw spectral data were background subtracted for direct acceptor excitation and 
peak-fitted using OriginPro. The ratio of the areas of acceptor emission over donor 
emission (FA/FD) using the integrals of the peak emissions were calculated and plotted to 
determine the linear and dynamic ranges of the sensors. 
To compare between the different sensors, the data were normalized to the no aTc 
controls and fitted to the following logistic function to determine EC50: 
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where A1 is the initial value, A2 is the final value,  is the concentration at which there 
is 50% signal, and p is the Hill coefficient. 
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3. RESULTS AND DISCUSSION 
By exploiting the difference in the binding affinity between the TF and its specific 
binding sequence in the presence and absence of a small molecule analyte, the TF-DNA 
binding and unbinding becomes a sensor for the small molecule effector (Figure 1). The 
transcription factor TetRc was used for this proof-of-concept sensing study because it is a 
well characterized allosteric TF that is used extensively for gene regulation and inducible 
protein expression in the laboratory setting.  
TetRc binds to the TetO DNA sequence in the absence of the effector molecule 
anhydrous tetracycline (aTc). The TetO cognate sequence comprises a 19 bp binding 
region. In the sensor design, the 19 bp cognate sequence was flanked by 4-5 bp on each 
side to ensure binding, resulting in a 28 bp DNA oligo. One of the strands was labeled with 
the FRET acceptor Cy5 on both the 5’ and 3’ ends. A second 28 bp sequence with no affinity 
for TetR was similarly labeled to act as the negative control (Table 1).   
Figure 1. Schematic of generalized FRET sensor using TF-DNA binding mechanism. 
Binding of the TF to a specific DNA sequence brings the donor and acceptor 
fluorophores into close proximity, enabling Förster resonance energy transfer (FRET). 
Upon binding of the effector analyte, the affinity of the TF for the DNA binding sequence 
is significantly reduced, resulting in unbinding of the TF-DNA complex. Therefore, 
energy transfer to the acceptor is minimal resulting in higher donor emission and lower 
acceptor emission intensities. Schematic not to scale. 
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Table 1. Synthetic DNA oligos for TetRc binding. 
Name Sequence a 
TetO4 (forward) 5’-GTCA TCCCTATCATTGATAGAGA TACTG-3’ 
TetO’ (reverse) 3’-CAGT AGGGATAGTAACTATCTCT ATGAC-5’ 
Scrambled (forward) 5’-TCGT GAAACCGAGCGAGGGACAC GCACA-3’ 
Scrambled (reverse) 3’-AGCA CTTTGGCTCGCTCCCTGTG CGTGT-5’ 
a The TetO binding sequence is the center region shown in blue; nucleotides labeled with 
Cy5 dye are labeled in red and underlined. 
 
3.1 The Effects of Different FRET Donors on Sensor Performance 
Two FRET-based sensors utilizing the TF-DNA binding mechanism were 
developed and characterized for the sensing of the small molecule aTc. Different FRET 
donors were used in order to investigate the effects of FRET efficiency and multi-valency 
on overall sensor performance. Each sensor consists of Cy5-modified DNA acting as the 
FRET acceptor with either a fluorescent protein-transcription factor (FP-TF) fusion protein 
(expressed in E. coli) or quantum dot-transcription factor (QD-TF) conjugate as the donor. 
The spectral overlap between the respective donor emission peaks and the Cy5 absorption 
for each sensor is shown in Figure 2A and Figure2C. The QD-Cy5 FRET pair exhibits 
increased spectral overlap compared to tdTomato (Table 2). The much higher quantum 
yield of tdTomato compared to the QDs, however, results in a larger calculated Förster 
distance, R0, for the tdTomato-Cy5 FRET pair than the calculated R0 for the QD-Cy5 FRET 
pair (Table 2). Thus, we would expect that in 1:1 donor: acceptor pairs with the same 
donor-acceptor distances, the tdTomato-Cy5 sensor would exhibit the most efficient 
energy transfer.  
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J (x 1016 M-1 cm-1 nm4) 
R0 
(nm) 
TetRc-tdTomato 69 1.34 7.43 
CdSe/4CdS/2ZnS QDs 23.4 2.69 6.96 
Acceptor 
Molar Extinction Coefficient 
(M-1 cm-1) 
Cy5 250,000 
Figure 2. Absorbance (dashed lines) and emission (solid lines) spectra of tdTomato (B) 
and QD (D) overlapping Cy5. Schematics of the FP-based (A) and QD-based (C) sensors 
highlight the differences in sensor geometry. The QD-based sensor allows the ability for 
multiple acceptors per donor whereas the FP-based sensor is inherently a 1:1 ratio. 
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While as-synthesized QDs can exhibit near unity QYs [20], the thiolate-based 
ligands that produce the smallest possible organic coating on the semiconductor surface for 
water solubility are widely known to significantly quench the QD photoluminescence due 
to the introduction of surface trap states [16, 38]. The thin organic coating is desirable both 
to reduce donor-acceptor distance and to facilitate histidine-tag-mediated self-assembly of 
the proteins to the QD surface [38]. Previous results from our lab have shown that a 
moderately thick shelled core/shell QD heterostructure can be used to improve the QD QY 
following ligand exchange while moderating the distance added between the donor and 
acceptor molecules for efficient energy transfer [9]. In this context, core/shell/shell QDs 
were utilized comprising of CdSe/4CdS/2ZnS, where the number before the shell 
composition indicates the number of atomic monolayers that were deposited on the core. 
The diameter of the semiconductor QD based on TEM imaging is 7.6 ± 1.1 nm while DLS 
of the water-soluble particles indicates a hydrodynamic diameter of 10 ± 2 nm, showing 
the minimal increase in size from the CL4 ligand coating. 
Despite the less favorable Förster overlap, the nanoparticle-based sensor has the 
advantage of multi-valency. Specifically, multiple his-tagged TFs can self-assemble 
stoichiometrically with a Poissonian distribution of proteins onto the QD surface [10, 15]. 
This enables the binding of multiple acceptor dye-labeled oligos to a single QD donor 
(Figure 2D). Adding multiple acceptor molecules has the benefit of increasing the FRET 
efficiency compared to a single acceptor at the same donor-acceptor distance. In contrast, 
a greater number of donors per acceptor reduces FRET efficiency (Figure 3) [10, 15]. 
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Figure 3. Distance dependency of FRET efficiency for multivalent systems. FRET 
efficiency increases as the number of acceptors per donor increases. In contrast, the 
presence of excess donors decreases FRET efficiency. Reproduced from [10]. 
 
Figure 4. Relative donor emission plots as a function of molar acceptor ratios using (A) 
tdTomato and (B) QDs as FRET donors. Ratios of donor to TF was fixed at 1:1 for the 
tdTomato-Cy5 sensor and 1:4 for the QD-Cy5 sensor. Controls (black) use a scrambled 
oligo sequence with no affinity to TetR to measure the collisional quenching. Data are 
mean +/- standard deviation for n = 3. 
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Binding of the Cy5-modified DNA to the TetR-modified donors was demonstrated 
by titrating increasing concentrations of the DNA; the donor concentration was adjusted to 
keep overall TF concentration constant at 200 nM. Upon increasing DNA concentration, 
there is increased donor quenching in both cases. The non-linear response to increasing 
acceptor concentration is seen, as is characteristic of FRET systems. The results were 
plotted using a modified Hill equation, as previously described [34]. There is less donor 
quenching when titrating a non-binding DNA sequence at the same concentrations, 
demonstrating specific binding and donor quenching (Figure 4). The linear response from 
the non-binding control is described by Stern-Volmer collisional quenching [15, 34]. 
Calculated FRET efficiencies demonstrate that the QD-Cy5 sensor exhibits a higher FRET 
efficiency (50%) compared to the tdTomato-Cy5 sensor (30%). These results agree with 
the hypothesis that the nanoparticle-based sensor would exhibit a higher FRET efficiency 
due to its inherent ability for multi-valency compared to TetR-tdTomato when the binding 
affinity of the TF to DNA is kept constant, despite having a lower calculated R0 value. 
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Figure 5. Relative QD emission plots as a function of DNAs per TF for both 4 TFs/QD 
and 6 TFs/QD ratios.  
 
The QD-based sensor was tested with 6 TFs per donor to determine if the FRET 
efficiency of the system could be increased. As shown in Figure 5, increases from 4 to 6 
TFs per QD did not significantly improve FRET efficiency. Thus, four his6-TetRc 
monomers were used per QD for subsequent sensor designs. Inherently, the ratio of 
fluorophores:TF is fixed at 1:1 for the TF-FP fusion protein-based sensor. 
A TF to DNA ratio was chosen for each sensor (3:1 for tdTomato, 4.5:1 for QDs) 
and kept constant for subsequent experiments testing sensor sensitivity to aTc. 
Photoluminescence spectra measured from sensors with increasing concentrations of aTc 
yielded changes in the ratio between the acceptor emission and donor emission (FA/FD). 
With increasing concentrations of aTc, the FA/FD values decreased indicating unbinding of 
the DNA from the TF, resulting in a recovery of donor emission and decrease in acceptor 
23
emission (Figure 6). No changes were observed when aTc was titrated into a solution of 
non-binding donor-acceptor pairs (scrambled controls). This indicates the specific recovery 
of donor emission (and reduction in acceptor emission) due to TF-DNA unbinding. 
 
Figure 6. (A, B) Representative spectral data of the sensors (TetR-tdTomato, QD-TetR) 
in response to aTc concentration. Recovery of donor fluorescence intensities in response 
to higher aTc concentrations demonstrate modulated unbinding of the DNA from the TF. 
(C, D) Ratio of acceptor fluorescence to donor fluorescence (FA/FD) as a function of aTc 
concentration. tdTomato sensor was prepared with a 1:1:3 ratio of tdTomato:TF:DNA 
whereas the QD sensor was prepared with a 1:4:18 ratio of QD:TF:DNA. tdTomato 
(200nM) and QD (50nM) concentrations were selected to keep TF concentration constant 









































Table 3. Summary of Logistic Fit Coefficients. 
Sensor Esensor EC50(nM) h 
Signal-to-
Noise Ratio 
tdTomato-Cy5 0.300 218 ± 9.18 1.57 ± 0.0802 6.20 
QD-Cy5 0.500 699 ± 26.4 2.37 ± 0.191 13.9 
 
Comparing sensor outputs during the titration of aTc revealed an inverse 
relationship between FRET efficiency and sensor sensitivity. The tdTomato-Cy5 sensor 
exhibited higher sensitivity compared to the QD-Cy5 sensor. This implies that the overall 
degree of acceptor unbinding in the presence of aTc defines the sensor’s sensitivity. The 
inherent 1:1 donor: acceptor ratio of the tdTomato-Cy5 sensor allows for the sensor 
components to exist only in two states at equilibrium when aTc is present: (1) TetRc-
tdTomato bound to Cy5-DNA and (2) TetRc-tdTomato unbound to Cy5-DNA. This allows 
for a much greater change in signal intensity between the two states. On the other hand, the 
multi-valency of the QD-Cy5 sensor allows for four different binding states from Cy5-
DNA and QD-TetRc being completely unbound to Cy5-DNA occupying all four binding 
sites of the QD-tetRc conjugate. The ability for the sensor to exist in multiple bound states 
hinders its sensitivity. A greater number of aTc molecules are required to transition 
between the maximum and minimum FRET states for the QD-based sensor as compared 
to the FP-TF-based sensor. In compromising on sensitivity, the QD-based sensor exhibited 
a higher signal-to-noise ratio, which can be beneficial in applications requiring benchtop 
devices. The next section of this work aims to explore the ability to improve the sensitivity 
of the QD-based sensor by changing the inherent affinity between the TF and DNA. 
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3.2 The Effects of Affinities between TF and DNA on Sensor Sensitivity 
Yang et al. demonstrated that the limit of detection of their transcription factor-
based sensor could be lowered by introducing point mutations into the its binding sequence. 
The point mutations lowered the affinity of the DNA to the TF, and thereby increasing 
sensitivity of the sensor in the presence of the effector analyte [33]. Fields et al. identified 
variants of the tetO sequence with differential affinity and therefore, resulting in different 
activator-driven expression levels [12]. They identified several tetO variants with activity 
levels ranging from 5% to 85% as compared to the wild-type sequence. We chose 3 of the 
tetO variants identified by Fields et al. with activity levels of 70%, 30% and 5% as 
compared to the wild-type to test with our QD sensor (Table A1). Theoretically, by 
reducing the affinity of the DNA for the TF, fewer effector molecules would be required 
to transition from the maximum and minimum binding states, thus, increasing sensitivity. 
All ratios and conditions for the sensor were kept the same as previously mentioned.  
Due to the lower binding affinity of the DNA to the TF, the signal-to-noise of the 
sensor decreases as the activity levels of the Cy5-DNA decreases (Figure 7A). This is 
directly related to the overall FRET efficiency of the system. Fewer initial binding events 
due to the lower affinity of the DNA to TF leads to fewer number of donor-acceptor pairs 
contributing to FRET. A normalized plot of the sensor response curves reveals, however, 
that there are no significant changes in the sensor’s sensitivity to aTc (Figure 7B).  
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Figure 7. (A) Response curves of the QD-TetRc sensor with Cy5-DNA of varying 
activity levels. Signal-to-noise ratio of the sensor decreases as activity levels of the Cy5-
DNA decreases. (B) Normalized FA/FD plot of the different QD-TetRc sensors reveals no 
significant change in aTc sensitivity. 
There are a few possible explanations for these results. As mentioned, Fields et al. 
were able to identify the tetO variants based on the expression levels of the LUC1 gene as 
determined by luciferase activity [12]. The KD of the tetO variants to TetRc was not directly 
measured. Although binding affinities play a heavy role, there are many confounders that 
can affect expression levels. The activity levels of the tetO variants may not be directly 
proportional to its binding affinity. Another explanation could be in the sensor 
configuration. During these assays, the ratios between the QD, TF, and DNA were kept 
constant based on previous results. Changing the ratios between these components could 
force the majority of donor-acceptor pairs into one of the different binding states instead. 
For example, a 1:1 ratio of QD:TF could be used to obtain a similar configuration to the 
TetRc-tdTomato, where only two binding states are possible. This increases sensitivity as 
previously shown. However, the Poissonian distribution of TF his-tagged binding should 
also be taken into consideration since unlabeled donors could hinder the overall detectable 
27
signal of the sensor.
 
Figure 8. Relative QD emission plot as a function of molar acceptor ratio using the 
TetRd protein variant. 
An alternative to adjusting binding affinities via the DNA sequence is to modify 
the TF itself. Many mutations of TetR are known to change its responsivity to the analyte; 
for example, revTetR reverses the binding mechanism causing TF-DNA binding in the 
presence of aTc rather than its absence [27]. The variant TetRd was identified from 
literature and used in subsequent studies to determine the ability of tuning the sensor output 
by subtly modifying the binding affinity of the TF to its DNA oligo. A QD with comparable 
spectral properties was also used in these studies for comparison (Figure A1, Table A2). 
Titration of Cy5-modified DNA into the QD-tetRd conjugate confirmed binding of 
the TetRd protein variant to the tetO sequence (Figure 8). However, the FRET efficiency
is greatly reduced (15%) compared to the QD-TetRc (40%) and TetRc-tdTomato (30%).
With similar sensor properties (i.e. spectral overlap, donor-acceptor distances, etc.), the 
lower FRET efficiency implies a lower binding affinity of TetRd to its DNA compared to 
TetRc. 
28
Figure 9. (A) Representative spectral data of QD-tetRd sensor in response to increasing 
concentrations of aTc. (B) FA/FD plot of the QD-tetRd sensor as a function of aTc 
concentration. 
The aTc response curves of the QD-TetRd sensor revealed an EC50 of 133 ± 6.15
nM, a 5-fold decrease compared to the QD-TetRc sensor (EC50 = 699 ± 26.4 nM) and 
roughly 1.6-fold decrease compared to the TetRc-tdTomato sensor (EC50 = 218 ± 9.18
nM) (Figure 9). This further supports the notion that FRET efficiency is inversely 
proportional to sensor sensitivity. The significant increase in sensitivity, however, comes 
with a large decrease in the signal-to-noise ratio (3.60) (Figure 9). Normalized plots of all 
three sensors utilizing the TetR protein are shown in Figure 10 for easy comparison.  
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Figure 10. Normalized FA/FD plots of the FRET-based sensors using the TetR 
transcription factor as a function of aTc concentration. 
We have generated proof-of-concept data showing that FRET is a valid optical 
readout for observing the binding and unbinding of a TF to its DNA sequence in the 
presence of its effector molecule. Furthermore, we have demonstrated the ability to alter 
the sensitivity of the sensor by modifying the TF and changing its affinity for the DNA.
This increase in sensitivity, however, comes with a sacrifice in the signal-to-noise ratio of 
the overall sensor. The next part of this work aims to apply this sensor scheme using a 
different TF that is responsive to a clinically relevant molecule of interest. 
3.3 Applying Sensor Design to Clinically Relevant TF  
We have shown that the TF-DNA binding mechanism can be exploited for analyte 
sensing using FRET. To further validate the QD sensor scheme, we tested the design using 
another TF of interest. A previously uncharacterized TF, AIY20223.2 (AIY), that is 
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responsive to progesterone and its binding sequence were identified and isolated by the 
Galagan group. Specific binding of the TF was shown by titration of the Cy5-modified 
DNA in increasing concentrations (Figure 11). The QD:TF:DNA ratio was kept constant 
at 1:4:18 as in previous studies. The calculated FRET efficiency of this system was 18%.  
 
Figure 11. Relative QD emission plot of the QD-AIY sensor as a function of molar 
acceptor ratio. 
Since AIY is known to be responsive to progesterone, we were curious to see if 
AIY was specific to progesterone or generally responsive to steroid hormones. Therefore, 
the QD-AIY sensor was tested with a variety of steroid hormones such as aldosterone, 
estrone, and estradiol in addition to progesterone. As shown in Figure 12, the QD-AIY 
sensor was highly responsive to progesterone and showed no response to estrone, or 
estradiol. There was, however, some cross reactivity with aldosterone, albeit with a much 
higher EC50 of 4660 ± 614 nM compared to an EC50 of 577 ± 30.0 nM for progesterone.
We also revisited the possibility that changing the ratio of TF to QD could affect its 
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sensitivity. In earlier studies, we tested a higher ratio of TF to QD in order to maximize 
FRET efficiency; however, our studies have shown that higher FRET efficiency does not 
result in higher sensitivity, but quite the opposite. Ratios of 3, 4, and 5 TFs per QD were 
tested and the normalized results are shown in Figure 13. No significant changes in 
sensitivity to progesterone were seen. More work should be done to probe the specific 
binding kinetics of AIY, its DNA, and progesterone to get a better understanding of which 
parameters are most important for tuning sensor performance. 
 
Figure 12. FA/FD plots of the QD-AIY sensor as a function of concentration of various 




Figure 13. Normalized sensor response curves as a function of progesterone 
concentration of QD-AIY sensors with varying TF to QD ratios.
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4. CONCLUSIONS AND FUTURE WORK 
We have shown that this TF-DNA binding mechanism is a reliable molecular 
recognition element in sensing applications and have successfully shown that FRET is a 
valid optical readout for observing the binding and unbinding of a TF to its DNA in the 
presence of an effector molecule. FRET can be effectively used with the TF-DNA binding 
mechanism regardless of donor-acceptor pairs. We have demonstrated the importance of 
selecting the appropriate donor-acceptor pair for the desired application. If a high signal-
to-noise ratio is required to be detected by off-the-shelf detectors, the QD-based sensor 
may be a better choice over the lower detection limit of the FP-based sensor and vice versa. 
Moreover, we have displayed the ability to tune sensor performance by altering the affinity 
of the TF for its DNA and the versatility of this sensor design as a whole. The modularity 
of the sensor allowed us to use an entirely different TF to detect and measure a molecule 
of interest. 
Because there were compromises in signal intensities of the sensors with respect to 
sensitivity for the multivalent QD systems, the configuration and ratios of the sensor 
components should be investigated further. Since it has been demonstrated that this sensor 
design scheme works regardless of donor-acceptor pairs, it would also be interesting to 
explore additional FRET pairs in future work.
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APPENDIX 
Table A1. Alternative DNA sequences for TetR with varying activity levels. 
Name Sequence a 
Original DNA (wt-tetO) 5’- CAGTATCTCTATCAATGATAGGGATGAC -3’ 
70% Activity 3’- CAGTATCTCTATCAATGATACGGATGAC -5’ 
30% Activity 5’- CAGTATCTCTATCAATGAGAGGGATGAC -3’ 
5% Activity 5’- CAGTATCTCTGTCCATGATAGGGATGAC -3’ 
 




J (x 1016 M-1 cm-1 nm4) 
R0 
(nm) 
CdSe/6CdS/2ZnS QDs 17.0 2.02 6.29 
Acceptor 




Table A3. Synthetic DNA oligos for AIY binding.  
Name Sequence a 
AIY_DNA (forward) 5’-GTCA TCCCTATCATTGATAGAGA TACTG-3’ 
AIY_DNA’ (reverse) 3’-CAGT AGGGATAGTAACTATCTCT ATGAC-5’ 
Scrambled (forward) 5’-TCGT GAAACCGAGCGAGGGACAC GCACA-3’ 




Figure A1. Absorbance (dashed line) and emission (solid line) spectra of QD2 used in 
AIY sensor.  
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